AX-202

• Description:

  AX-202 is a human monoclonal antibody (mAb) targeting S100A4. AX-202 has antifibrotic effects in the mouse Tsk-1 model. AX-202 can be used in Plaque psoriasis and Systemic scleroderma research[1].

• UNSPSC:

  12352203

• Target:

  Myosin

• Related Pathways:

  Cytoskeleton

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Purity:

  98.76

• Smiles:

  [AX-202]

• References & Citations:

  [1]Tomčík M, et al. Op0245 anti-S100A4 monoclonal antibody treatment ameliorates skin fibrosis in inflammatory and non-inflammatory pre-clinical models of systemic sclerosis[J]. 2021.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  -80°C

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported